---
$id: https://graph.org.ai/products/commodity/51181627
$type: Product
source: UNSPSC
code: "51181627"
title: "Liothyronine sodium"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Liothyronine sodium

**UNSPSC Code**: 51181627
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a generic primary tumor tnm finding with the molecular formula C15H11I3NO4.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GCA9VV7D2N, chemically known as l-tyrosine, o-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt, but more generally known as liothyronine sodium, which bears US NIH Compound Identifier 5919. European Medicines Agency schedules liothyronine sodium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08527MIG. Most nations, for tariff purposes, schedule liothyronine sodium under HS 29374000. Liothyronine sodium bears US NLM identifiers UMLS ID C0546882 and NCI Concept Code C2581. SMILES: C1CC(C(CC1OC2C(CC(CC2I)C[C@@H](C(=O)[O-])N)I)I)O.[NA+].

